- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Tiotropium placebo
Total 53650 results
-
University of Colorado, DenverNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)WithdrawnType I DiabetesUnited States
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveGermany, United States
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States
-
AstraZenecaTerminatedChronic Obstructive Pulmonary Disease | COPDPoland, Sweden
-
NovartisCompletedChronic Obstructive Pulmonary Disease (COPD)Spain, Germany, South Africa, Australia, Poland, New Zealand, Netherlands
-
Hamilton Health Sciences CorporationUnknown
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Argentina, Australia, Austria, Belgium, Brazil, Czech Republic, Denmark, Finland, France, Germany, Greece, Hong Kong, Hungary, Ireland, Italy, Japan, Lithuania, Malaysia, Mexico, Netherlands, New Zealand, Norway, Philip... and more
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)Germany
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaTerminatedChronic Obstructive Pulmonary DiseaseItaly
-
Federal University of São PauloCompletedPulmonary Disease, Chronic Obstructive | Pulmonary Emphysema | Chronic BronchitisBrazil
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseUnited States
-
NovartisCompletedChronic Obstructive Pulmonary DiseaseGermany
-
The First Affiliated Hospital of Guangzhou Medical...Boehringer Ingelheim; Rundo International Pharmaceutical Research & Development...CompletedChronic Obstructive Pulmonary DiseaseChina
-
Boehringer IngelheimPfizerCompletedPulmonary Disease, Chronic ObstructiveUnited States, Canada
-
Mayo ClinicPfizer; Boehringer IngelheimCompletedChronic Obstructive Pulmonary Disease | COPDUnited States
-
Boehringer IngelheimPfizerCompletedPulmonary Disease, Chronic ObstructiveUnited States, Belgium, Canada, Czech Republic, Germany, Greece, Netherlands, Portugal, Ukraine, United Kingdom
-
Boehringer IngelheimPfizerCompletedPulmonary Disease, Chronic Obstructive | ExerciseUnited States, Argentina, Brazil, Canada, Germany, Italy, Portugal, Russian Federation, Spain, Taiwan, Ukraine
-
Boehringer IngelheimCompletedAsthmaGermany, Denmark, Netherlands
-
Laval UniversityBoehringer IngelheimCompletedChronic Obstructive Pulmonary DiseaseCanada
-
Theron Pharmaceuticals, Inc.CompletedAsthmaUnited States
-
AstraZenecaCompleted
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseAustralia, New Zealand
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)Colombia, India, Korea, Republic of, Poland, Croatia, Estonia, Hungary, United Kingdom, Israel, Latvia, Turkey, Argentina, Panama, Mexico, Russian Federation, Serbia, Slovenia
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveArgentina, Germany, Romania, Russian Federation, Estonia, Peru, Poland, France, Chile, Hungary, Italy, Slovakia
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Czech Republic, Germany, Hungary, Poland
-
Boehringer IngelheimPfizerCompletedAsthmaUnited States, Belgium, Finland, Germany, Korea, Republic of, Latvia, Lithuania, Malaysia, Netherlands, Philippines, Ukraine
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic Obstructive
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveAustria, Canada, Spain, United States, Finland, Italy, Russian Federation, United Kingdom, New Zealand, Australia, France, Greece, Ireland, Netherlands, South Africa
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary DiseaseUnited States
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseSweden
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Germany
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic Obstructive | AsthmaNetherlands, Germany, Belgium, France, Canada, Italy, South Africa, Denmark
-
GlaxoSmithKlineCompleted
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Belgium, Canada, Czech Republic, Denmark, Finland, Germany, South Africa, Spain, United Kingdom
-
Boehringer IngelheimPfizerCompletedAsthmaUnited States, Australia, Canada, Denmark, Germany, Italy, Japan, Netherlands, New Zealand, Russian Federation, Serbia, South Africa, Turkey, Ukraine, United Kingdom
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimTerminated
-
Mylan Inc.Theravance BiopharmaCompletedChronic Obstructive Pulmonary Disease, COPD | Low Peak Inspiratory Flow Rate (PIFR)United States
-
Queen's UniversityBoehringer IngelheimCompletedChronic Obstructive Pulmonary DiseaseCanada
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Puerto Rico
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveGermany
-
Novartis PharmaceuticalsCompleted
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Australia, Austria, Canada, Germany, Greece, New Zealand, Norway, Slovakia, South Africa, Sweden
-
Boehringer IngelheimPfizerCompletedAsthmaUnited States, Australia, Canada, Denmark, Germany, Italy, Japan, Netherlands, Russian Federation, Serbia, South Africa, Turkey, Ukraine, United Kingdom
-
Boehringer IngelheimPfizerCompleted